Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Wy 49051

😃Good
Catalog No. T13352Cas No. 113418-56-7
Alias Wy-49051

Wy 49051 is an orally active antagonist of H1 receptor(IC50 of 44 nM).

Wy 49051

Wy 49051

😃Good
Purity: 99.89%
Catalog No. T13352Alias Wy-49051Cas No. 113418-56-7
Wy 49051 is an orally active antagonist of H1 receptor(IC50 of 44 nM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$106-In Stock
5 mg$209-In Stock
10 mg$303-In Stock
25 mg$475-In Stock
50 mg$638-In Stock
100 mg$826-In Stock
200 mg$1,100-In Stock
1 mL x 10 mM (in DMSO)$230-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.89%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Wy 49051 is an orally active antagonist of H1 receptor(IC50 of 44 nM).
Targets&IC50
H1 receptor:44 nM
In vitro
Wy 49051 showed a great inhibitory effect on H1. At a concentration of 100 nM, it produced 92% inhibition of histamine-induced guinea pig ileal contraction. Wy 49051 is the most effective compound, with 700 times the potency of astemizole and 470 times the potency of hydroquinone. Wy 49051 also has high affinity for α1 receptor with IC50 of 8 nM[1].
In vivo
Wy 49051 demonstrates efficacy in counteracting histamine-induced lethality in guinea pigs, with effective doses (ED50) of 1.91 mg/kg orally (po), 0.70 mg/kg intraperitoneally (ip), and 0.01 mg/kg intravenously (iv). Additionally, the compound maintains its oral efficacy without any reduction for up to 18 hours posttreatment[1].
SynonymsWy-49051
Chemical Properties
Molecular Weight487.59
FormulaC28H33N5O3
Cas No.113418-56-7
SmilesC(CCN1CCC(OC(C2=CC=CC=C2)C3=CC=CC=C3)CC1)N4C5=C(N(C)C(=O)N(C)C5=O)N=C4
Relative Density.1.25 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (92.29 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (10.25 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0509 mL10.2545 mL20.5090 mL102.5452 mL
5 mM0.4102 mL2.0509 mL4.1018 mL20.5090 mL
10 mM0.2051 mL1.0255 mL2.0509 mL10.2545 mL
20 mM0.1025 mL0.5127 mL1.0255 mL5.1273 mL
50 mM0.0410 mL0.2051 mL0.4102 mL2.0509 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Wy 49051 | purchase Wy 49051 | Wy 49051 cost | order Wy 49051 | Wy 49051 chemical structure | Wy 49051 in vivo | Wy 49051 in vitro | Wy 49051 formula | Wy 49051 molecular weight